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Abstract
Some patients recover from COVID-19, but their reverse
transcription-polymerase chain reaction (RT-PCR) for SARSCoV-2 remains persistently positive. In the evaluation of these
patients, it is important to define the cycle threshold (Ct) value
of the RT-PCR test. This article will present a case study, ad-

dress relevant findings and interpretation of the RT-PCR test,
and explain the use of Ct values in defining when a healthcare worker may return to work. Our current approach is to
allow health care workers with persistently positive RT-PCR
to return to work if the Ct value is greater than 35.

Introduction

for SARS-CoV-2 at intervals of 24 hours or longer for
discontinuation of isolation in a convalescent patient
with COVID-19.[5] Unfortunately, there are some challenges in the best interpretation of test results including
communication with high risk individuals (e.g. elderly
with major comorbidities, etc), those hospitalized patients stable enough to return to or enter chronic care facilities, and those recovering from the COVID-19 with
persistent positive tests. This article will present a case
study and address relevant findings and interpretation
of the diagnostic RT-PCR test in respiratory specimens
to assist clinicians in their communications and action
plans.

The coronavirus disease of 2019 (COVID-19) pandemic
is causing a shocking death toll in large because of
the high transmissibility of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the severity of illness in about 20% of cases.[1] It is imperative to
have a reliable test for early identification of individuals with SARS-CoV-2 infection. A reliable SARS-CoV2 test will be instrumental for identification of people
with the infection, preventing the spread and mitigating the epidemic.[2] Additionally, a highly reliable test
will allow early interventions that include isolation and
appropriate medical care of the infected persons that in
turn will be translated into the protection of the community at risk.
In a short period of time, there has been substantial
progress in the confirmation of COVID-19 by a positive
SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR) test in a symptomatic patient.[3] However, there are important uncertainties in relation to
the best interpretation of the test in different scenarios.[4] It remains to be determined what is the best
interpretation of a negative RT PCR assay in a symptomatic patient. It is becoming an established practice
to use two consecutive negative respiratory samples
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Case Study
A 39-year old registered nurse was evaluated at the
hospital employee health clinic due to sore throat and
fever. She works on the general medicine ward. During her evaluation, a nasopharyngeal swab sample was
obtained for SARS CoV-2 RT-PCR. The result of the RTPCR test was positive. She was not complaining of
cough or shortness of breath. Her social history and
past medical history were unremarkable. Her temperature was 101.5 °F, heart rate 95 bpm, repiratory rate 18
bpm, blood pressure 125/80 mmHg, and oxygen sat-
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Figure 1. Schematic representation of the cycle threshold values for the health care worker described in the case study.

uration of 96% on room air. The final diagnosis was
COVID-19. She was advised to begin home isolation,
to call if any clinical deterioration, and to plan on returning to clinic in 14 days for evaluation before returning to work. When she returned to the clinic on
day 14, she was afebrile and had been asymptomatic
for 8 days. The repeat SARS CoV-2 RT-PCR was positive. The patient returned to clinic on day 22, and the
SARS CoV-2 RT-PCR was again positive. She was advised to return to clinic again in 7 days. On day 29, the
repeat RT-PCR was still positive and at this time the patient had been asymptomatic for 23 days. The hospital
policy stated that a healthcare worker needed to have
a demonstrated negative RT-PCR before returning to
work. To further evaluate the case, the cycle threshold
(Ct) values were collected for each of the four RT-PCR
tests. A graphic representation of the Ct values for the
patient are depicted in Figure 1.
Since the last Ct value was elevated at 38, it was considered that the patient was no longer infectious and she
was allowed to return to work.

SARS-CoV-2 RT-PCR Assay
There are many internal and external factors of the
SARS-CoV-2 RT PCR test accounting for the optimal diagnostic yield.
Internal factors
This paper is directed to clinicians therefore some internal factors of the SARS-CoV-2 RT PCR assay are beyond
the aim of this paper. The main internal factors of the
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RT PCR include the target genes and cycle threshold
(Ct).
Genes target for the SARS-CoV-2 assays: Currently
the most sensitive SARS-CoV-2 RT PCR assays use the
genes N1, N2 and E. The Centers for Disease Control
and Prevention (CDC) recommends the genes N1 and
N2 encoding the two nucleocapsid proteins and the
human RNase P gene to confirm the ribonucleic acid
(RNA) extraction. On the other hand, the World Health
Organization (WHO) recommends the assay using the
gene E; which requires a confirmatory assay using the
RdRp gene. Both assays have high analytic sensitivity
and specificity for SARS-CoV-2.[6] These two assays are
highly specific for SARS-CoV-2 with no cross-reactivity
with other respiratory viruses as reported by Nalla et al.
in an evaluation of assays using seven different primerprobe sets and one assay kit.[7]
The basics on the cycle threshold: Real-time assay
is a type of PCR assay where positive reactions (nucleic acid amplifications) are detected by accumulation
of the fluorescent signal in real-time. As the cycles of
the real-time PCR continue, the fluorescent signal increases exponentially by two-fold and it becomes significantly higher from the background, called ‘threshold’. The cycle number at which the signal crosses the
threshold is called a cycle threshold (Ct) (Figure 1). Ct
levels are inversely proportional to the amount of the
target nucleic acid in the sample. This means that the
lower the Ct value the greater the amount of the target
nucleic acid in the sample and vice-versa.
The cut off for positive and negative Ct for SARS CoV-2
remains unclear. However, a good number of authors
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recommend a cut off of 40.[2, 6, 8] It means a test is considered positive if the Ct is < 40 and vice-versa. On the
other hand, the European Centre for Disease Prevention and Control (ECDC) considers the Ct cut off of 35
and a Ct value > 35 considers that it could be the result
from a contaminant. ECDC recommends all positive
results to be confirmed by a second gene target.[9] Holshue et al. reported the first case of COVID-19 in the US
and the NP Cts on the days 4, 7, 11 and 12 were 12-18,
23-24, 33-34 and 37-40 respectively.[10] Similar trend of
increasing Ct values over time were reported by others.[11]
External factors
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tion of 712 (19.18%) persons out of 3,711 passengers and
crew members.[14] Ninety (2.4%) persons had asymptomatic SARS-CoV-2 infection with a median age of
59.5 years. Among the asymptomatic persons, 20% had
arterial hypertension and 9% diabetes mellitus. The
median number of days between the first positive PCR
test and the first of the two serial negative PCR tests
was 9 days. These results of positive SARS-CoV-2 RTPCR highlights the unique nature of COVID-19, which
can be asymptomatic and contagious. The confirmation of asymptomatic COVID-19 transmitting the infection to others demands to consider universal testing as
a strategy to identify the source of infection.
RT-PCR test during the symptomatic infection

Biological specimens: Samples from the respiratory
tract are the most recommended specimens to test for
SARS-CoV-2. A nasopharyngeal specimen (NP) is the
preferred choice for swab-based SARS-CoV-2 testing,
but oropharyngeal, mid-turbinate, anterior nares samples, sputum and tracheal aspirate and bronchoalveolar lavage also are acceptable specimens. However, the
yield of a positive test is not the same for each type of
specimen and also it depends on the time of the course
of the infection.[12] The yield for positive tests were
reported to be greater for sputum and bronchoalveolar lavage (BAL) than the NP, OP and nasal swabs.[12]
Improper collection of respiratory specimens could be
sources of false-negative tests.

SARS-CoV-2 RT-PCR and Timing of Testing
Positive SARS-CoV-2 RT-PCR results have been reported during the incubation time of COVID-19 when
patients are asymptomatic, during the symptomatic period and lastly during convalescence time when the patients become asymptomatic. On the other hand, there
are pending answers to the interpretation of the results
of SARS-CoV-2 RT-PCR during these three time points
of the illness and its translation to infectivity.
RT-PCR test during the asymptomatic infection
Rothe et al. reported SARS-CoV-2 RT-PCR from an
asymptomatic individual who turned to be the original
source of infection, also known as “ the index case”, for
an individual who became the source for infection of 3
other individuals. The transmissions from the asymptomatic index case to patient 1 and from patient 1 to
patients 2 to 4 occurred in a total of 7 days. All these
persons including the index case subsequently developed mild illness characterized by fever and mild respiratory symptoms and all had positive SARS-CoV-2
from respiratory sources. In this series, one person had
a viral load of 108 copies/ml of sputum.[13] The outbreak of COVID-19 on the cruise ship Diamond Princess
illustrates the SARS-CoV-2 among asymptomatic persons. This outbreak resulted in the SARS-CoV-2 infec-
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Zou et al. monitored SARS-CoV-2 viral load of nasal
and swab swabs from 18 patients in relation to the
symptom onset.[15] Lower Ct, higher viral load, were
detected soon after the symptoms onset. Interestingly,
the viral loads and Ct were similar regardless of the
presence of the symptoms. In most individuals with
symptomatic COVID-19 infection, the viral RNA is
detectable as early as day 1 of symptoms and peaks
within the first week of symptom onset in nasopharyngeal swab.[11] In patients without severe COVID-19,
the SARS-CoV-2 detection declines by week 3 to undetectable. On the other hand, in severe COVID-19 the
SARS-CoV-2 detection may persist longer than 3 weeks
after illness onset. It remains to be determined whether
the persistent SARS-CoV-2 is viral infectivity.[11, 16]
RT-PCR test after the symptomatic infection or convalescence
Interpreting the result of a SARS-CoV-2 test depends on
the accuracy of the test and the pre-test probability or
estimated risk of disease before testing. Pre-test probability is in relation to the prevalence of the illness under evaluation and it influences the accuracy of the test
result. The SARS-CoV-2 RT-PCR tests were reported
to have a sensitivity of 70% and a specificity of 98% [6
,16]. SARS-CoV-2 RT-PCR has been reported to remain
positive in sputum and BAL when the NP swabs become negative.[11] Positive SARS-CoV-2 viral cultures
have not been reported after day 8 of symptoms onset.[11, 16] Though positive SARS-CoV-2 RT-PCR has
been reported beyond many weeks following the first
positive test, it is tempting to think that positive SARSCoV-2 RT-PCR results after day 8 of symptom onset
may not be infectious. Persistent positive tests have
been reported in some conditions that were not infections e.g. persistent positive acid-fast bacilli on staining test paired to negative cultures in patients receiving
treatment for tuberculosis with resolving symptoms.
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RT-PCR

Sensitivity

and

group, noinfectious viruses were rescued from clinical
NP samples that have Ct >30.

Because PCR generates two copies of product at each
cycle, the difference of 1 in Ct value indicates a difference of the target by a two-fold in the input sample. For
example, a sample with a Ct of 20 might have 1024-fold
higher amount of copy number than that with a Ct of 30
(230–20). Low Ct values clearly indicate the presence
of high target copy numbers in the sample; however,
high Ct values (weak positives) could be due to artifactual effects, such as noisy signal, random amplification,
or potential contamination. All positive results should
therefore be confirmed by a second gene target. For
this reason, most of real-time PCR test for SARS-CoV-2
use two targets. Only samples with positive results for
the both of two targets are determined as positive for
SARS-CoV-2. In case only one of the two is positive,
it is considered as “undetermined” and recommended
for a second test.

Positive SARS-CoV-2 RT-PCR and infectivity:
Bullard et al. examined the relationship between SARSCoV-2 RT-PCR Ct values from respiratory samples,
symptom onset to test (STT) and infectivity in Vero cell
lines culture.[16] Viral growth was seen in only 28.9%
of samples. Interestingly, there was no growth in samples with a Ct >24 or STT >8 days. They concluded
that infectivity may be low in patients with Ct >24
and duration of symptoms longer than 8 days. Similarly, Wolfel et al. reported no SARS-CoV-2 grows in
specimens collected after 8 days of the onset of symptoms.[11]

Generally, a real-time PCR shows an extremely high
sensitivity, with a detection limit of 1–10 copies per
sample and this holds true for the published real-time
PCR assays for SARS-CoV2. This means that a sample with a Ct at the cut-off for positive (e.g., 40) might
have 1–10 copies of RNA in the sample. Considering
the fact that the target of the most of real-time PCR assays for SARS-CoV2 is N gene, which is present in all
species of viral mRNA and genomic RNA, high Ct values should be carefully interpreted as it cannot indicate
the presence of infectious virus or active replications
(i.e., genomic RNA). In an unpublished study for our
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Conclusion
Ct values appear to play an important role when the
test-based discontinuation of isolation of the patient is
considered. It appears that infectivity is low in patients
with Ct values greater than 24. In the case study presented in this manuscript, the healthcare worker was
asymptomatic with a Ct value of 38 at day 29 after the
initial positive RT-PCR. It was considered that the positive RT-PCR likely reflected the presence of residual viral genomic RNA, without the presence of live viruses.
The healthcare worker was deemed non-infectious and
she was allowed to return to work. Our current approach is to allow to return to work healthcare workers
with persistently positive RT-PCR if the Ct values are
greater than 35.
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